STANDARD BIOTOOLS INC. (LAB) › Operating Cash FlowSTANDARD BIOTOOLS INC. (LAB) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2009: -$19.51M2010: -$11.51M2011: -$17.54M2012: -$17.48M2013: -$1.59M2014: -$22.62M2015: -$34.73M2016: -$39.14M2017: -$24.10M2018: -$25.20M2019: -$35.21M2020: -$15.42M2021: -$44.06M2022: -$89.37M2023: -$43.29M2024: -$143.45M2025: -$74.34M-$74.34M2009Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$74.34M+48.2%2024-$143.45M-231.4%2023-$43.29M+51.6%2022-$89.37M-102.8%2021-$44.06M-185.8%2020-$15.42M+56.2%2019-$35.21M-39.7%2018-$25.20M-4.6%2017-$24.10M+38.4%2016-$39.14M-12.7%2015-$34.73M-53.5%2014-$22.62M-1321.9%2013-$1.59M+90.9%2012-$17.48M+0.4%2011-$17.54M-52.4%2010-$11.51M+41.0%2009-$19.51M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share